This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase II, multi-centre, randomised, double-blind...
Clinical trial

A Phase II, multi-centre, randomised, double-blind, placebo-controlled, parallel group study to investigate the efficacy, safety and tolerability of Cogane� (PYM50028), a novel, orally active neurotrophic factor inducer, in male and female subjects with e

Read time: 1 mins
Last updated:9th Aug 2010
To determine whether PYM50028 exhibits clinical benefit in the treatment of subjects with early-stage Parkinson�s disease (PD), as assessed by the Unified Parkinson�s Disease Rating Scale score for Parts II and III combined (UPDRS II/III), compared with placebo.
Category Value
Study start date 2010-08-09

View full details